Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-24 @ 6:48 PM
NCT ID:
NCT03231657
Eligibility Criteria:
Inclusion Criteria:
* Ability to read and understand informed consent.
* Unique pregnancies.
* \> 24 weeks and \<41 weeks
* Suspected preeclampsia:
1. 140/90 or worsening of chronic hypertension
2. Onset of proteinuria (Labstick + or proteinuria\> 300mg / 24 hours) or worsening of it
3. Preeclampsia prodromal clinic such as epigastric, headache, photopsia, tinnitus and increased edema in the face hands or legs or weight gain (\> 1 kg per week in the third trimester)
4. Analytical alterations: decrease in platelets \<100,000. Increased transaminases.
5. Ultrasound alterations: Small fetus for gestational age or restriction of interatrial growth, increased resistance of the uterine arteries.
* Pre-eclampsia (ACOG Practice Bulletin 2013)
Exclusion Criteria:
* Multiple pregnancies
* \<24 weeks of gestation
* Fetal chromosomal or congenital abnormalities
* Conditions that require immediate delivery (eclampsia, pulmonary edema, uncontrolled hypertension, severe visual disturbances, severe headache, fetal demise, non-reassuring fetal status….)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03231657
Study Brief:
Protocol Section:
NCT03231657